| Patent | Date |
|---|
Pichia Pastoris Strains For Producing Predominantly Homogeneous Glycan Structure
App 20220145311 - Gehlsen; Kurt R. ; et al. | 2022-05-12 |
Pichia pastoris strains for producing predominantly homogeneous glycan structure
Grant 11,220,692 - Gehlsen , et al. January 11, 2 | 2022-01-11 |
Small antibody-like polypeptides that bind to EPHA2 receptor
Grant 10,829,558 - Gehlsen , et al. November 10, 2 | 2020-11-10 |
Pichia Pastoris Strains For Producing Predominantly Homogeneous Glycan Structure
App 20200190526 - Gehlsen; Kurt R. ; et al. | 2020-06-18 |
Pichia pastoris strains for producing predominantly homogeneous glycan structure
Grant 10,612,033 - Gehlsen , et al. | 2020-04-07 |
Engineered Stable Ch2 Polypeptides
App 20200031912 - GEHLSEN; Kurt R. | 2020-01-30 |
Pichia Pastoris Strains For Producing Predominantly Homogeneous Glycan Structure
App 20190256860 - Gehlsen; Kurt R. ; et al. | 2019-08-22 |
Pichia pastoris strains for producing predominantly homogeneous glycan structure
Grant 10,329,572 - Gehlsen , et al. | 2019-06-25 |
Pichia pastoris surface display system
Grant 10,113,164 - Gehlsen , et al. October 30, 2 | 2018-10-30 |
Ribotoxin molecules derived from sarcin and other related fungal ribotoxins
Grant 9,976,131 - Gehlsen , et al. May 22, 2 | 2018-05-22 |
Fusion proteins comprising immunoglobulin constant domain-derived scaffolds
Grant 9,803,210 - Bramhill , et al. October 31, 2 | 2017-10-31 |
Small Antibody-like Polypeptides That Bind To Epha2 Receptor
App 20170306032 - Gehlsen; Kurt R. | 2017-10-26 |
Fusion Proteins Comprising Immunoglobulin Constant Domain-derived Scaffolds
App 20170298369 - BRAMHILL; David ; et al. | 2017-10-19 |
Ribotoxin Molecules Derived From Sarcin And Other Related Fungal Ribotoxins
App 20170204387 - Gehlsen; Kurt R. ; et al. | 2017-07-20 |
Pichia Pastoris Strains For Producing Predominantly Homogeneous Glycan Structure
App 20170166910 - Gehlsen; Kurt R. ; et al. | 2017-06-15 |
Pichia pastoris strains for producing predominantly homogeneous glycan structure
Grant 9,617,550 - Gehlsen , et al. April 11, 2 | 2017-04-11 |
Ribotoxin molecules derived from sarcin and other related fungal ribotoxins
Grant 9,603,911 - Gehlsen , et al. March 28, 2 | 2017-03-28 |
Pichia Pastoris Surface Display System
App 20170002346 - GEHLSEN; Kurt R. ; et al. | 2017-01-05 |
Ribotoxin Molecules Derived From Sarcin And Other Related Fungal Ribotoxins
App 20160106819 - Gehlsen; Kurt R. ; et al. | 2016-04-21 |
Pichia Pastoris Strains For Producing Predominantly Homogeneous Glycan Structure
App 20150267212 - Gehlsen; Kurt R. ; et al. | 2015-09-24 |
Multimeric Proteins Comprising Immunoglobulin Constant Domains
App 20130189247 - Bramhill; David ; et al. | 2013-07-25 |
Use of histamine and related compounds to treat disorders affecting muscle function
App 20060002913 - Gehlsen; Kurt R. | 2006-01-05 |
Use of histamine to treat bone disease
App 20050171192 - Gehlsen, Kurt R. | 2005-08-04 |
Methods and compositions for promoting the maturation of monocytes
Grant 6,893,633 - Hellstrand , et al. May 17, 2 | 2005-05-17 |
Methods and compositions for promoting the maturation of monocytes
Grant 6,821,510 - Hellstrand , et al. November 23, 2 | 2004-11-23 |
Synergistic tumorcidal response induced by histamine
App 20040219153 - Gehlsen, Kurt R. ; et al. | 2004-11-04 |
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
App 20040191239 - Hellstrand, Kristoffer ; et al. | 2004-09-30 |
Methods and compositions for promoting the maturation of monocytes
Grant 6,790,440 - Hellstrand , et al. September 14, 2 | 2004-09-14 |
Reactive oxygen metabolite inhibitors for use in compositions and methods of treatment
App 20040120926 - Hellstrand, Kristoffer ; et al. | 2004-06-24 |
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
Grant 6,730,692 - Hellstrand , et al. May 4, 2 | 2004-05-04 |
Use of ROM production and release inhibitors to treat and prevent intraocular damage
App 20030228277 - Gehlsen, Kurt R. | 2003-12-11 |
Elevation of circulating blood histamine levels
Grant 6,613,788 - Hellstrand , et al. September 2, 2 | 2003-09-02 |
Compositions for the treatment of infectious diseases
App 20030149090 - Gehlsen, Kurt R. ; et al. | 2003-08-07 |
Use of histamine to treat liver disease
App 20030091553 - Gehlsen, Kurt R. | 2003-05-15 |
Activation and protection of T-cells (CD4+ and CD8+) using an H2 receptor agonist and other T-cell activating agents
App 20030039628 - Hellstrand, Kristoffer ; et al. | 2003-02-27 |
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
App 20030017145 - Hellstrand, Kristoffer ; et al. | 2003-01-23 |
Synergistic tumorcidal response induced by histamine
App 20020193416 - Gehlsen, Kurt R. ; et al. | 2002-12-19 |
Methods and compositions for promoting the maturation of monocytes
App 20020182177 - Hellstrand, Kristoffer ; et al. | 2002-12-05 |
Methods and compositions for promoting the maturation of monocytes
App 20020182176 - Hellstrand, Kristoffer ; et al. | 2002-12-05 |
Methods and compositions for promoting the maturation of monocytes
App 20020182175 - Hellstrand, Kristoffer ; et al. | 2002-12-05 |
Methods and compositions for promoting the maturation of monocytes
App 20020182174 - Hellstrand, Kristoffer ; et al. | 2002-12-05 |
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
App 20020150565 - Hellstrand, Kristoffer ; et al. | 2002-10-17 |
Ophthalmic histamine compositions and uses thereof
App 20020098224 - Gehlsen, Kurt R. | 2002-07-25 |
Methods and compositions for promoting the maturation of monocytes
App 20020094323 - Hellstrand, Kristoffer ; et al. | 2002-07-18 |
Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
App 20020095001 - Gehlsen, Kurt R. | 2002-07-18 |
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
App 20010023256 - Hellstrand, Kristoffer ; et al. | 2001-09-20 |
Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
App 20010018059 - Gehlsen, Kurt R. | 2001-08-30 |
Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
Grant 6,270,781 - Gehlsen August 7, 2 | 2001-08-07 |
Adhesion receptor for laminin and its use
Grant 5,180,809 - Ruoslahti , et al. January 19, 1 | 1993-01-19 |
| 